The Effect of Oral Administration of L-Tyrosine, Folic acid and Pyridoxine on Perphenazine Induced Catatonia in Rat

Authors

Ardeshir Arzi1,*, Mohsen Rezaei1
1Department of Pharmacology, School of Pharmacy, Ahvaz University of Medical Sciences, Ahvaz, Iran
*Corresponding Author: Department of Pharmacology, School of Pharmacy, Ahvaz University of Medical Sciences, Ahvaz, Iran. Email:[email protected]

IJ Pharmaceutical Research:Vol. 2, issue 3; 167-171
Published online:Nov 20, 2010
Article type:Research Article
Received:May 01, 2003
Accepted:Aug 01, 2003
How to Cite:Arzi A, Rezaei M. The Effect of Oral Administration of L-Tyrosine, Folic acid and Pyridoxine on Perphenazine Induced Catatonia in Rat. Iran J Pharm Res. 2022;2(3):e127960. doi: https://doi.org/10.22037/ijpr.2010.42

Abstract

L-tyrosine, B6 and folic acid are involved in biosynthesis of DOPA and consequently dopamine. The aim of this study was to investigate the antiparkinsonian effect of these agents in perphenazine-induced catatonia in rats. Murprogo method or scored muscular rigidity, which is induced by a phenothiazine, was used to evaluate the antiparkinsonian effect of these agents. A significant decrease in muscular rigidity was observed in groups that received L-tyrosine. However, groups which had received vitamin(s) only showed no significant decrease in muscular rigidity as compared with the control group. On the other hand, the group receiving folic acid plus L-tyrosine showed a lower degree of muscular rigidity in comparison with the other groups.

In conclusion, L-tyrosine has been found to be effective in improving perphenazine-induced muscular rigidity. Furthermore, when used in combination with folic acid, L-tyrosine could be found advantageous in the early stages of Parkinson's disease.

Copyright

© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Mar
2007

THE EFFECT OF L-TYROSINE, VITAMINS E AND C ON PERPHENAZINE-INDUCED CATATONIA IN RAT

A Arzi,
AA Hemmati,
S Ghobishavi,
L Arzi

Arzi A, Hemmati A, Ghobishavi S, Arzi L. THE EFFECT OF L-TYROSINE, VITAMINS E AND C ON PERPHENAZINE-INDUCED CATATONIA IN RAT. Jundishapur J Nat Pharm Prod. 2007;2(1):. doi:

20
Dec
2006

THE EFFECT OF SELEGILINE AND BROMOCRIPTINE IN THE PROPHYLAXIS OF PERPHENAZINE-INDUCED PSEUDOPARKINSONISM IN RAT: A COMPARATIVE STUDY

A Arzi,
A.A Hemmati,
M.H Pipelzadeh,
S.M Latifi,
F Ramesh

Arzi A, Hemmati A, Pipelzadeh M, Latifi S, Ramesh F. THE EFFECT OF SELEGILINE AND BROMOCRIPTINE IN THE PROPHYLAXIS OF PERPHENAZINE-INDUCED PSEUDOPARKINSONISM IN RAT: A COMPARATIVE STUDY. Jundishapur J Nat Pharm Prod. 2006;1(1):. doi:

12
Aug
2025
Behavioral Outcomes and Histopathological Alterations in a Rotenone-induced Parkinson’s Disease Model: A Comparative Study of L-Dopa and Apomorphine

Behavioral Outcomes and Histopathological Alterations in a Rotenone-induced Parkinson’s Disease Model: A Comparative Study of L-Dopa and Apomorphine

Sayed Mostafa Modarres Mousavi,
Fatemeh Alipour,
Shima Lotfollahzadeh,
Faezeh Mousazadeh,
Hasan Hosseini,
Saman Hosseinkhani
,et al.

Modarres Mousavi SM, Alipour F, Lotfollahzadeh S, Mousazadeh F, Hosseini H, et al. Behavioral Outcomes and Histopathological Alterations in a Rotenone-induced Parkinson’s Disease Model: A Comparative Study of L-Dopa and Apomorphine. J Rep Pharm Sci. 2025;13(1):e162472. doi: https://doi.org/10.5812/jrps-162472

22
Jul
2015

Effect of potassium channel blocker 4-aminopyridine pretreatment on the 6-OHDA-induced Parkinson's disease in rats

M Sofiabadi,
hashem haghdoost-yazdi,
M Mahmudi,
H Pri,
T Dargahi,
M Yaghubidust

Sofiabadi M, haghdoost-yazdi H, Mahmudi M, Pri H, Dargahi T, et al. Effect of potassium channel blocker 4-aminopyridine pretreatment on the 6-OHDA-induced Parkinson's disease in rats. J Inflamm Dis. 2024;19(2):e155895. doi:

13
Jul
2016

Effect of potassium channel blocker of Tetraethylammonium pretreatment on prevention of the 6-OHDA-induced chronic Parkinson\'s disease in rats

Hashem Haghdoost-Yazdi,
Soheila sehat bakhsh,
Mohammad Sofiabadi,
Tahereh Dargahi,
MH Yaghubidust,
Hossein Piri

Haghdoost-Yazdi H, sehat bakhsh S, Sofiabadi M, Dargahi T, Yaghubidust M, et al. Effect of potassium channel blocker of Tetraethylammonium pretreatment on prevention of the 6-OHDA-induced chronic Parkinson\'s disease in rats. J Inflamm Dis. 2024;20(2):e155962. doi:

More by these authors

Ardeshir ArziPubMedScholar
Mohsen RezaeiPubMedScholar
Share
Cited by
Metrics